IMVT Immunovant, Inc.
Healthcare$34.29+0.00%OpenMarket Cap: $7.04B
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$43.67
Target (Median)
$41.00
Target Range
$40.00 - $50.00
Upside from current price: 27.4%
Rating Distribution
2 Strong Buy11 Buy5 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-22 | Truist Securities | maintain | Hold | Hold |
| 2026-05-21 | B of A Securities | maintain | Buy | Buy |
| 2026-05-21 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-04-15 | Goldman Sachs | maintain | Neutral | Neutral |
| 2026-02-10 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-02-09 | Guggenheim | maintain | Buy | Buy |
| 2026-01-08 | Truist Securities | maintain | Hold | Hold |
| 2026-01-06 | Wolfe Research | upgrade | Outperform | Peer Perform |
| 2025-12-15 | Goldman Sachs | maintain | Neutral | Neutral |
| 2025-09-30 | JP Morgan | maintain | Overweight | Overweight |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Wed Mar 31 | $-2.55 | $6.6M | 10 |
| Fri Mar 31 | $-2.52 | $85.3M | 9 |
| Sat Mar 31 | $-1.50 | $450.4M | 9 |
| Sun Mar 31 | $0.54 | $1.02B | 3 |